B
Barbara A. Goff
Researcher at University of Washington
Publications - 235
Citations - 12862
Barbara A. Goff is an academic researcher from University of Washington. The author has contributed to research in topics: Ovarian cancer & Cancer. The author has an hindex of 61, co-authored 227 publications receiving 11859 citations. Previous affiliations of Barbara A. Goff include Georgetown University & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Surgical Stage IV Endometrial Carcinoma: A Study of 47 Cases
Barbara A. Goff,Annekathryn Goodman,Howard G. Muntz,Arlan F. Fuller,Najmosama Nikrui,Laurel W. Rice +5 more
TL;DR: A 15-year retrospective review revealed that prognosis for women with Stage IV endometrial cancer is extremely poor as mentioned in this paper, however, if hysterectomy with cytoreduction is feasible, surgery should be performed because survival may be improved.
Journal ArticleDOI
The significance of psammoma bodies in screening cervical cytologic smears.
TL;DR: This study suggests that the presence of psammoma bodies in normal cytologic smears of asymptomatic women is an incidental finding.
Journal ArticleDOI
Combination chemotherapy in advanced adenocarcinoma of the fallopian tube
Howard G. Muntz,Howard G. Muntz,Hector M. Tarraza,Barbara A. Goff,Cornelius O. Granai,Laurel W. Rice,Najmosama Nikrui,Arlan F. Fuller +7 more
TL;DR: Advanced adenocarcinoma of the fallopian tube has a poor prognosis, with 5-year survival rates commonly less than 20%.
Journal Article
Post-hysterectomy carcinoma of the fallopian tube mimicking a vesicovaginal fistula.
TL;DR: A 49-year-old woman presented with a profuse watery vaginal discharge 16 years after a vaginal hysterectomy and Exploratory surgery revealed fallopian tube carcinoma involving the right tube.
Journal ArticleDOI
Accuracy of ovarian and colon cancer risk assessments by U.S. physicians.
Laura Mae Baldwin,Katrina F. Trivers,C. Holly A. Andrilla,Barbara Matthews,Jacqueline W. Miller,Denise M. Lishner,Barbara A. Goff +6 more
TL;DR: Physicians’ misestimation of patient ovarian and colon cancer risk may put average risk patients in jeopardy of unnecessary screening and higher risk patientsIn jeopardy of missed opportunities for prevention or early detection of cancers.